Glycogen Storage Disease Type II
"Glycogen Storage Disease Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4)
Descriptor ID |
D006009
|
MeSH Number(s) |
C10.228.140.163.100.435.340 C16.320.565.189.435.340 C16.320.565.202.449.500 C16.320.565.595.554.340 C18.452.132.100.435.340 C18.452.648.189.435.340 C18.452.648.202.449.500 C18.452.648.595.554.340
|
Concept/Terms |
Glycogen Storage Disease Type II- Glycogen Storage Disease Type II
- Acid Maltase Deficiency Disease
- Deficiency Disease, Acid Maltase
- Deficiency Disease, Lysosomal alpha-1,4-Glucosidase
- GAA Deficiency
- Deficiencies, GAA
- Deficiency, GAA
- GAA Deficiencies
- Generalized Glycogenosis
- Generalized Glycogenoses
- Glycogenoses, Generalized
- Glycogenosis, Generalized
- Glycogen Storage Disease II
- Glycogen Storage Disease Type 2
- Glycogenosis 2
- Glycogenosis Type II
- Type II, Glycogenosis
- Type IIs, Glycogenosis
- GSD II
- Lysosomal alpha-1,4-Glucosidase Deficiency Disease
- Lysosomal alpha 1,4 Glucosidase Deficiency Disease
- Pompe Disease
- Disease, Pompe
- Pompe's Disease
- Disease, Pompe's
- Pompes Disease
- Deficiency of Alpha-Glucosidase
- Alpha-Glucosidase Deficiencies
- Alpha-Glucosidase Deficiency
- Deficiency of Alpha Glucosidase
- GSD2
- GSD2s
- Acid Alpha-Glucosidase Deficiency
- Acid Alpha Glucosidase Deficiency
- Acid Alpha-Glucosidase Deficiencies
- Alpha-Glucosidase Deficiencies, Acid
- Alpha-Glucosidase Deficiency, Acid
- Deficiencies, Acid Alpha-Glucosidase
- Deficiency, Acid Alpha-Glucosidase
Acid Maltase Deficiency- Acid Maltase Deficiency
- Acid Maltase Deficiencies
- Deficiencies, Acid Maltase
- Deficiency, Acid Maltase
- Maltase Deficiencies, Acid
- Alpha-1,4-Glucosidase Deficiency
- Alpha 1,4 Glucosidase Deficiency
- Alpha-1,4-Glucosidase Deficiencies
- Deficiencies, Alpha-1,4-Glucosidase
- Deficiency, Alpha-1,4-Glucosidase
|
Below are MeSH descriptors whose meaning is more general than "Glycogen Storage Disease Type II".
- Diseases [C]
- Nervous System Diseases [C10]
- Central Nervous System Diseases [C10.228]
- Brain Diseases [C10.228.140]
- Brain Diseases, Metabolic [C10.228.140.163]
- Brain Diseases, Metabolic, Inborn [C10.228.140.163.100]
- Lysosomal Storage Diseases, Nervous System [C10.228.140.163.100.435]
- Glycogen Storage Disease Type II [C10.228.140.163.100.435.340]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Metabolism, Inborn Errors [C16.320.565]
- Brain Diseases, Metabolic, Inborn [C16.320.565.189]
- Lysosomal Storage Diseases, Nervous System [C16.320.565.189.435]
- Glycogen Storage Disease Type II [C16.320.565.189.435.340]
- Carbohydrate Metabolism, Inborn Errors [C16.320.565.202]
- Glycogen Storage Disease [C16.320.565.202.449]
- Glycogen Storage Disease Type II [C16.320.565.202.449.500]
- Lysosomal Storage Diseases [C16.320.565.595]
- Lysosomal Storage Diseases, Nervous System [C16.320.565.595.554]
- Glycogen Storage Disease Type II [C16.320.565.595.554.340]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Brain Diseases, Metabolic [C18.452.132]
- Brain Diseases, Metabolic, Inborn [C18.452.132.100]
- Lysosomal Storage Diseases, Nervous System [C18.452.132.100.435]
- Glycogen Storage Disease Type II [C18.452.132.100.435.340]
- Metabolism, Inborn Errors [C18.452.648]
- Brain Diseases, Metabolic, Inborn [C18.452.648.189]
- Lysosomal Storage Diseases, Nervous System [C18.452.648.189.435]
- Glycogen Storage Disease Type II [C18.452.648.189.435.340]
- Carbohydrate Metabolism, Inborn Errors [C18.452.648.202]
- Glycogen Storage Disease [C18.452.648.202.449]
- Glycogen Storage Disease Type II [C18.452.648.202.449.500]
- Lysosomal Storage Diseases [C18.452.648.595]
- Lysosomal Storage Diseases, Nervous System [C18.452.648.595.554]
- Glycogen Storage Disease Type II [C18.452.648.595.554.340]
Below are MeSH descriptors whose meaning is more specific than "Glycogen Storage Disease Type II".
This graph shows the total number of publications written about "Glycogen Storage Disease Type II" by people in this website by year, and whether "Glycogen Storage Disease Type II" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 | 2006 | 1 | 0 | 1 | 2009 | 1 | 0 | 1 | 2010 | 2 | 0 | 2 | 2015 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glycogen Storage Disease Type II" by people in Profiles.
-
Karam C, Ragole T, Moshe-Lilie O, Chahin N. Unwarranted, long term, alglucosidase alfa enzyme replacement therapy in two non-Pompe disease patients. Clin Neurol Neurosurg. 2020 09; 196:106048.
-
Bandyopadhyay S, Wicklund M, Specht CS. Novel presentation of Pompe disease: Inclusion-body myositis-like clinical phenotype. Muscle Nerve. 2015 Sep; 52(3):466-7.
-
Barker PC, Pasquali SK, Darty S, Ing RJ, Li JS, Kim RJ, DeArmey S, Kishnani PS, Campbell MJ. Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. Mol Genet Metab. 2010 Dec; 101(4):332-7.
-
Dixon CA, Anderson JB, Ruddy RM, Cripe LH. Infantile-onset Pompe disease: a diagnosis not to miss. Pediatr Emerg Care. 2010 Apr; 26(4):293-5.
-
Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, Arnold GL, Pivnick EK, Ottinger CJ, Robinson PH, Loo JC, Smitka M, Jardine P, Tat? L, Chabrol B, McCandless S, Kimura S, Mehta L, Bali D, Skrinar A, Morgan C, Rangachari L, Corzo D, Kishnani PS. Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Med. 2009 Mar; 11(3):210-9.
-
Ansong AK, Li JS, Nozik-Grayck E, Ing R, Kravitz RM, Idriss SF, Kanter RJ, Rice H, Chen YT, Kishnani PS. Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med. 2006 May; 8(5):297-301.
-
Ing RJ, Cook DR, Bengur RA, Williams EA, Eck J, Dear Gde L, Ross AK, Kern FH, Kishnani PS. Anaesthetic management of infants with glycogen storage disease type II: a physiological approach. Paediatr Anaesth. 2004 Jun; 14(6):514-9.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|